Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chengxuan Qiu. (2011) Epidemiological findings of vascular risk factors in Alzheimer’s disease: implications for therapeutic and preventive intervention. Expert Review of Neurotherapeutics 11:11, pages 1593-1607.
Read now
Read now
Angel Cedazo-Mínguez, Muhammad-Al-Mustafa Ismail & Laura Mateos. (2011) Plasma cholesterol and risk for late-onset Alzheimer’s disease. Expert Review of Neurotherapeutics 11:4, pages 495-498.
Read now
Read now
Articles from other publishers (23)
Vipul Chaudhary, Ashwini Kumar Nigam, Ashutosh Paliwal, Manoj Kumar Singh, Jalaj Kumar Gour & Vimlendu Bhushan Sinha. 2021. Naturally Occurring Chemicals Against Alzheimer's Disease. Naturally Occurring Chemicals Against Alzheimer's Disease
65
82
.
Young-Kook Kim & Juhyun Song. (2020) Potential of Glucagon-Like Peptide 1 as a Regulator of Impaired Cholesterol Metabolism in the Brain. Advances in Nutrition 11:6, pages 1686-1695.
Crossref
Crossref
Jessica Sarahi Alavez-Rubio & Teresa Juarez-Cedillo. (2019) ACAT1 as a Therapeutic Target and its Genetic Relationship with Alzheimer's Disease. Current Alzheimer Research 16:8, pages 699-709.
Crossref
Crossref
Xiaoling Li, Xiaoquan Zhu, Wandong Zhang, Fan Yang, Juan Hui, Jiping Tan, Haiqun Xie, Dantao Peng, Lihua Ma, Lianqi Cui, Shouzi Zhang, Zeping Lv, Liang Sun, Huiping Yuan, Qi Zhou, Luning Wang, Shige Qi, Zhihui Wang, Caiyou Hu & Ze Yang. (2018) The etiological effect of a new low-frequency ESR1 variant on Mild Cognitive Impairment and Alzheimer’s Disease: a population-based study. Aging 10:9, pages 2316-2337.
Crossref
Crossref
Kyle B. Smith, Paul Kang & Marwan N. Sabbagh. (2017) The effect of statins on rate of cognitive decline in mild cognitive impairment. Alzheimer's & Dementia: Translational Research & Clinical Interventions 3:2, pages 149-156.
Crossref
Crossref
Keith A. Hawkins, Nazli Emadi, Godfrey D. Pearlson, Anderson M. Winkler, Beth Taylor, Latha Dulipsingh, Diana King, Brian Pittman & Karen Blank. (2017) Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients. Metabolic Brain Disease 32:3, pages 849-857.
Crossref
Crossref
Vivek Gupta, Veer B. Gupta, Nitin Chitranshi, Sumudu Gangoda, Roshana Vander Wall, Mojdeh Abbasi, Mojtaba Golzan, Yogita Dheer, Tejal Shah, Alberto Avolio, Roger Chung, Ralph Martins & Stuart Graham. (2016) One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina. Cellular and Molecular Life Sciences 73:22, pages 4279-4297.
Crossref
Crossref
Kristine Yaffe & Adina Zeki Al Hazzouri. 2016. The Behavioral Neurology of Dementia. The Behavioral Neurology of Dementia
44
56
.
Jarosław Sławek & Monika Białecka. 2015. Diet and Nutrition in Dementia and Cognitive Decline. Diet and Nutrition in Dementia and Cognitive Decline
423
433
.
Sachiko Nomura, Tomohiro Umeda, Takami Tomiyama & Hiroshi Mori. (2013) The E693Δ (Osaka) mutation in amyloid precursor protein potentiates cholesterol-mediated intracellular amyloid β toxicity via its impaired cholesterol efflux. Journal of Neuroscience Research 91:12, pages 1541-1550.
Crossref
Crossref
SUN HAENG PARK, JI HYUN KIM, KYUNG HA CHOI, YOUNG JUNG JANG, SUN SIK BAE, BYUNG TAE CHOI & HWA KYOUNG SHIN. (2013) Hypercholesterolemia accelerates amyloid β-induced cognitive deficits. International Journal of Molecular Medicine 31:3, pages 577-582.
Crossref
Crossref
Vincent Gullo & Arnold Demain. 2013. Chemistry and Pharmacology of Naturally Occurring Bioactive Compounds. Chemistry and Pharmacology of Naturally Occurring Bioactive Compounds
435
444
.
Tomohiro Umeda, Takami Tomiyama, Erika Kitajima, Toshiki Idomoto, Sachiko Nomura, Mary P. Lambert, William L. Klein & Hiroshi Mori. (2012) Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice. Life Sciences 91:23-24, pages 1169-1176.
Crossref
Crossref
Francesca Mangialasche, Miia Kivipelto, Alina Solomon & Laura Fratiglioni. (2012) Dementia prevention: current epidemiological evidence and future perspective. Alzheimer's Research & Therapy 4:1, pages 6.
Crossref
Crossref
Nathan Herrmann, Sarah A. Chau, Ida Kircanski & Krista L. Lanctôt. (2011) Current and Emerging Drug Treatment Options for Alzheimerʼs Disease. Drugs 71:15, pages 2031-2065.
Crossref
Crossref
Christopher M. Valdez, Clyde F. Phelix, Mark A. Smith, George Perry & Fidel Santamaria. (2011) Modeling cholesterol metabolism by gene expression profiling in the hippocampus. Molecular BioSystems 7:6, pages 1891.
Crossref
Crossref
Diane R. Mould. 2011. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development
57
90
.
Robin AltmanJohn C. Rutledge. (2010) The vascular contribution to Alzheimer's disease. Clinical Science 119:10, pages 407-421.
Crossref
Crossref
Sonia Campoy, Saleta Sierra, Beatriz Suarez, Maria C Ramos, Javier Velasco, Javier S Burgos & Jose L Adrio. (2010) Semisynthesis of novel monacolin J derivatives: hypocholesterolemic and neuroprotective activities. The Journal of Antibiotics 63:8, pages 499-505.
Crossref
Crossref
Bernard G. Schreurs. (2010) The effects of cholesterol on learning and memory. Neuroscience & Biobehavioral Reviews 34:8, pages 1366-1379.
Crossref
Crossref
Francesca Mangialasche, Alina Solomon, Bengt Winblad, Patrizia Mecocci & Miia Kivipelto. (2010) Alzheimer's disease: clinical trials and drug development. The Lancet Neurology 9:7, pages 702-716.
Crossref
Crossref
Tomohiro Umeda, Hiroshi Mori, Hui Zheng & Takami Tomiyama. (2010) Regulation of cholesterol efflux by amyloid β secretion. Journal of Neuroscience Research 88:9, pages 1985-1994.
Crossref
Crossref
Ta‐Yuan Chang, Catherine C. Y. Chang, Elena Bryleva, Maximillian A. Rogers & Stephanie R. Murphy. (2010) Neuronal cholesterol esterification by ACAT1 in Alzheimer's disease. IUBMB Life 62:4, pages 261-267.
Crossref
Crossref